Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System
Authors
Discussion
Loading...
Member takes
Implication
Expert consensus proposes standardized efficacy endpoint definitions for adjuvant breast cancer trials, highlighting improved cross-trial comparability and meta-analysis accuracy.
Key Points
- Establish standardized definitions for efficacy endpoints and events in early-stage adjuvant breast cancer clinical trials to ensure consistent interpretation and facilitate cross-trial comparisons.
- An expert panel comprising specialists in medical oncology, biostatistics, and correlative science convened to evaluate discrepancies in trial endpoints.
- The panel developed standard definitions for key efficacy outcomes and systematically categorized the individual clinical events that constitute each endpoint.
- The STEEP system was formulated to establish uniform criteria for defining breast cancer events and efficacy endpoints across clinical trials.
- The framework allows for prospective customization for trial-specific questions while serving as a model for standardizing endpoints in other oncology settings.
Cite This Study
Hudis et al. (2007) studied this question.